Initial Approach to Treating Hyponatremia
The initial approach to treating hyponatremia must be determined by assessing symptom severity, volume status (hypovolemic, euvolemic, or hypervolemic), and serum osmolality, with immediate hypertonic saline reserved for severe symptomatic cases and tailored management based on the underlying etiology for all others. 1
Immediate Assessment Steps
Determine symptom severity first – this dictates urgency of intervention 1:
- Severe symptoms (seizures, coma, altered mental status, cardiorespiratory distress) require immediate treatment 1, 2
- Mild symptoms (nausea, headache, confusion) allow time for diagnostic workup 1
- Asymptomatic cases permit methodical evaluation 1
Obtain essential initial laboratory tests 1, 3:
- Serum sodium, serum osmolality, urine osmolality, and urine sodium concentration 1, 3
- Assess extracellular fluid volume status through physical examination (orthostatic hypotension, skin turgor, mucous membranes, edema, ascites) 1, 3
- Serum uric acid <4 mg/dL suggests SIADH with 73-100% positive predictive value 1, 3
Treatment Based on Symptom Severity
For Severe Symptomatic Hyponatremia (Medical Emergency)
Administer 3% hypertonic saline immediately 1, 2, 4:
- Give 100-150 mL bolus over 10 minutes, repeatable up to 3 times at 10-minute intervals 1, 4
- Target correction: 6 mmol/L over first 6 hours or until symptoms resolve 1, 2
- Critical safety limit: Never exceed 8 mmol/L correction in 24 hours to prevent osmotic demyelination syndrome 1, 2, 4
- Monitor serum sodium every 2 hours during initial correction 1
For Asymptomatic or Mildly Symptomatic Hyponatremia
Treatment depends on volume status 1, 5:
Hypovolemic hyponatremia (orthostatic hypotension, dry mucous membranes, decreased skin turgor) 1, 5:
- Discontinue diuretics immediately 1
- Administer isotonic saline (0.9% NaCl) for volume repletion 1, 5
- Urine sodium <30 mmol/L predicts good response to saline (71-100% positive predictive value) 1, 3
Euvolemic hyponatremia (SIADH) (no edema, normal blood pressure, normal skin turgor) 1, 6:
- Fluid restriction to 1 L/day is first-line treatment 1, 2, 6
- Add oral sodium chloride 100 mEq three times daily if no response to fluid restriction 1
- Consider urea or vaptans (tolvaptan 15 mg daily) for resistant cases 1, 2
Hypervolemic hyponatremia (edema, ascites, jugular venous distention) 1, 5:
- Implement fluid restriction to 1-1.5 L/day for sodium <125 mmol/L 1, 5
- Discontinue diuretics temporarily 1
- Consider albumin infusion in cirrhotic patients 1
- Avoid hypertonic saline unless life-threatening symptoms present – it worsens fluid overload 1
Critical Correction Rate Guidelines
Standard correction rates 1, 2, 4:
- Maximum 8 mmol/L in 24 hours for average-risk patients 1, 2, 4
- High-risk patients require slower correction: 4-6 mmol/L per day 1, 4
High-risk populations for osmotic demyelination syndrome 1, 2:
- Advanced liver disease, alcoholism, malnutrition 1, 2
- Severe hyponatremia (<120 mmol/L) 1
- Prior encephalopathy 1
Special Considerations in Neurosurgical Patients
Distinguish SIADH from cerebral salt wasting (CSW) – treatments are opposite 1, 6:
SIADH characteristics 1, 3, 6:
- Euvolemic state, urine sodium >20-40 mmol/L, urine osmolality >300 mOsm/kg 3, 6
- Treat with fluid restriction 1, 6
Cerebral salt wasting characteristics 1, 3:
- True hypovolemia with low CVP (<6 cm H₂O), urine sodium >20 mmol/L despite volume depletion 1, 3
- Treat with volume and sodium replacement, NOT fluid restriction 1, 6
- Consider fludrocortisone for severe symptoms 1
- Never use fluid restriction in subarachnoid hemorrhage patients at risk of vasospasm 1
Common Pitfalls to Avoid
- Overly rapid correction exceeding 8 mmol/L in 24 hours causes osmotic demyelination syndrome 1, 2, 4
- Using fluid restriction in cerebral salt wasting worsens outcomes 1
- Inadequate monitoring during active correction 1
- Failing to recognize and treat the underlying cause 1
- Using hypertonic saline in hypervolemic hyponatremia without life-threatening symptoms 1
- Ignoring mild hyponatremia (130-135 mmol/L) – even this increases fall risk and mortality 1, 2